On May 1, 2023, ODAIA announced a $34 million Series B financing round. This round was co-led by Threshold Ventures and Monograph Capital, who are both focused on life sciences and healthtech companies. With this financing, ODAIA plans to extend their presence within North America and beyond.
ODAIA is a Toronto based start-up that utilizes artificial intelligence to collect and analyze pharmaceutical data.
Osler, Hoskin & Harcourt LLP advised ODAIA with a team consisting of Chad Bayne, Ryan Unruch, Sahil Chopra, Jordana Corber-Tovel, Nataly Dil, Handi Xu (Emerging and High Growth Companies).